Position
D. E. Shaw & Co., Inc. in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $466K$2.05 → $2.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.11M | $2.27M | — | — | — | 0.0% |
| Q1 2026 | 1.94M | $4.8M | $2.47 | $466K | $2.06M | 0.0% |